| Literature DB >> 35183144 |
Amy Booth1, Astrid Louise Wester2.
Abstract
BACKGROUND: Antimicrobial resistance (AMR) is a public health concern. We wanted to determine if various environmental and socioeconomic variables as well as markers of antimicrobial use impacted on the level of AMR in countries of different income levels.Entities:
Keywords: Antimicrobial resistance; Antimicrobial usage; Corruption; Quinolone-resistant Escherichia coli; Wastewater, sanitation, and hygiene
Mesh:
Substances:
Year: 2022 PMID: 35183144 PMCID: PMC8857829 DOI: 10.1186/s12889-022-12776-y
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 4.135
Description and sources of variables used
| Definition | Unit | Data Source (data year) | |
|---|---|---|---|
| Proportion of blood culture | % | CDDEP Resistance Map (2020) [ WHO GLASS Report Early Implementation (2017–2018) [ | |
| Proportion of a country’s population using a sanitation service that does not meet the criteria for safely managed sanitation, that is “use of improved facilities that are not shared with other households and where excreta are safely disposed of in situ or transported and treated offsite” | % | WHO/UNICEF JMP Report on Progress on Drinking Water, Sanitation and Hygiene (2017) [ | |
| Proportion of a country’s population using a drinking water service that does not meet the criteria for safely managed drinking water, that is “drinking water from an improved water source that is located on premises, available when needed and free from faecal and priority chemical contamination” | % | WHO/UNICEF Joint Monitoring Program Report on Progress on Drinking Water, Sanitation and Hygiene (2017) [ | |
| Defined Daily Doses (DDD) of fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, norfloxacin) consumed per 1000 population per year | DDD/1000/y | CDDEP Resistance Map (2015) [ | |
| DDD of all antibiotics consumed per 1000 population per year | DDD/1000/y | CDDEP Resistance Map (2015) [ | |
| Total antimicrobial consumption by animals per year in mg per population correction unit (PCU) | Mg/PCU | CDDEP Resistance Map (2013) [ | |
| Population per square kilometre of land area | Pop/km2 | World Bank (2019) [ | |
| The sum of value (in US dollars) added by all resident producers in a country plus any product taxes not included in the valuation of output plus net receipts of primary income from abroad, divided by the mid-year population | US dollars | World Bank (2019) [ | |
| A ranking of countries, on a scale of 1 to 100, based on their perceived levels of corruption (misuse of public power for private benefit), as determined by expert assessments and opinion surveys | NA | Transparency International (2019) [ | |
| The mean number of completed years of education | Years | Our World in Data – Global Education (2017) [ | |
| A score out of a total of 100 based on measuring mortality rates from diseases that should not be fatal in the presence of effective medical care | NA | Our World in Data -Healthcare Access and Quality (2015) [ | |
| Average national temperature in degrees Celsius | °C | Lebanese Economy Forum (2015) [ | |
| Index of production of meat and milk from all sources, dairy products such as cheese, and eggs, honey, raw silk, wool and hides and skins relative to the base period 2004–2006 | NA | World Bank (2016) [ | |
| Index of agricultural production for each year relative to the base period 2004–2006 | NA | World Bank (2016) [ | |
| Quantity of cultivated fish and crustaceans taken from marine and inland waters and sea tanks in metric tons | Metric Tons | World Bank (2016) [ |
CDDEP Center for Disease Dynamics Economics and Policy, WHO World Health Organization, NA Not applicable, UNICEF UN Children’s Fund, JMP Joint Monitoring Program, WIDE World Inequality Database on Education, UNESCO UN Educational, Scientific and Cultural Organization
Fig. 1Proportion of QREC (%) among blood culture isolates of E. coli, by country and income level. Data on QREC (%) among blood culture E. coli were extracted from the Center for Disease Dynamics, Economics and Policy (CDDEP) Resistance map, for which sources were the World Health Organization’s Global Antimicrobial Surveillance System (GLASS), regional databases such as European Antimicrobial Resistance Surveillance Network (EARS-net), Central Asian and Eastern European Surveillance of Antimicrobial Resistance Network (CAESAR), and country-based or single institution-based systems. For most countries, the year of data production was 2016 or 2017, however some were produced in 2015 (New Zealand, Mexico, Zimbabwe, Kenya), 2014 (Canada, Chile, Ecuador, Kosovo), 2013 (Venezuela), and 2009 (Sri Lanka)
Descriptive statistics
| Number of countries with data on potential explanatory variables | Median level (IQR) | ||
|---|---|---|---|
| Blood culture QREC (%) | 71 | 34 (25–49) | |
| Unsafely Managed Sanitation (%) | 67 | 2 (0–9) | |
| Unsafely Managed Water (%) | 66 | 0 (0–5·3) | |
| Human Fluoroquinolone Consumption (DDD/ 1000 population/ year) | 57 | 722 (426–1129·5) | |
| Total Human Antimicrobial Consumption (DDD/ 1000 population/ year) | 57 | 7760 (5868–11,030·5) | |
| Animal Antimicrobial Consumption (mg/PCU) | 54 | 60 (38–77) | |
| Population Density (population per square kilometre) | 69 | 93 (34–198·5) | |
| Gross National Income (US dollars) | 70 | 16,935 (6248–42,467·5) | |
| Corruption Perceptions Index (score 1–100, higher score indicative of lower corruption levels) | 70 | 53 (39–73·2) | |
| Education Level (years) | 68 | 11 (9–12) | |
| Healthcare Access and Quality (score 1–100) | 70 | 79 (71–87) | |
| Average Annual Temperature (degrees Celsius) | 67 | 11 (8–22) | |
| Livestock Production Index | 69 | 109 (97–129·5) | |
| Crop Production Index | 69 | 110 (95–128·5) | |
| Aquaculture Production Index | 68 | 30,630 (6687–216,186·5) | |
Fig. 2Scatterplot graphs of the linear regression analysis for all variables in all countries. Strengths of the associations are given in R-squared values
Multivariable linear regression model results for independent risk factors for blood culture QREC (%) isolates tested
| Blood Culture QREC (%) | |||
|---|---|---|---|
| All Countries | High-Income Countries | Middle-Income Countries § | |
| 0.09 (0.39) | – | 0.13 (0.16) | |
| 0.39 (0.44) | – | – | |
| 0.01 (0.00) *** | 0.01 (0.01) | – | |
| 0.00 (0.00) | 0.00 (0.00) | – | |
| −0.45 ((0.16) *** | −0.29 (0.14) ** | − 0.58 (0.38) | |
| −0.22 (1.45) | − 0.61 (1.09) | – | |
| − 0.03 (0.31) | − 0.64 (0.29) ** | − 0.23 (0.41) | |
| 0.29 (0.26) | 0.242 (0.27) | – | |
| 0.17 (0.08) ** | – | – | |
| 0.16 (0.07) ** | – | – | |
| – | 0.02 (0.04) | – | |
| – | 0.01 (0.01) | – | |
| 10.90 (38.44) | 93.96 (33.98) ** | 83.63 (26.69) *** | |
| 53 | 33 | 26 | |
| 0.73 | 0.73 | 0.29 | |
DDD Defined Daily Doses
§Malawi included
*** p < 0.01, ** p < 0.05, * p < 0.1
Tests for bias: Number of missing observations; Little’s MCAR Test; Chi-square Test
| Number of missing observations | MCAR’s Test: Prob > chi-square | |
|---|---|---|
| 4 | 0·90 | |
| 5 | 0·85 | |
| 14 | 0·01 | |
| 14 | 0·01 | |
| 17 | 0·03 | |
| 2 | 0·41 | |
| 1 | 0·39 | |
| 1 | 0·14 | |
| 3 | 0·36 | |
| 1 | 0·06 | |
| 4 | 0·83 | |
| 2 | 0·47 | |
| 2 | 0·47 | |
| 3 | 0·31 |